Preview: Os Therapies Incorporated Set To IPO Tomorrow

OS Therapies Incorporated OSTX IPO will take place July, 31 on the NYSE exchange under the ticker OSTX.

The company is offering shares at an expected price of $4.00 per share with an insider lock-up period of 180 days ending on January 27, 2025.

See also: Benzinga IPO Calendar

About OS Therapies Incorporated

OS Therapies Incorporated is a clinical stage biopharmaceutical company. The Company focuses on the identification, development, and commercialization of treatments for osteosarcoma (OS) and other solid tumors.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.